BSE filing, NSE: YATHARTH. Summary written from the filing by ALFA Finder's alert engine.
Yatharth Hospital & Trauma Care Services Ltd: key numbers
- Share price
- ₹1,027.25
- Market cap
- ₹9,898 Cr
- Revenue (annual)
- ₹1,207 Cr
- Net profit (annual)
- ₹175.4 Cr
- P/E (TTM)
- 52.0×Sector 53.4×
- Promoter holding
- 55.80%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yatharth Hospital & Trauma Care Services Ltd
All →Yatharth Hospital & Trauma Care Services Earnings Call Transcript: Key Takeaways
Yatharth delivered record performance driven by newer acquisitions turning EBITDA positive and a strategic 3,150 Cr Advent partnership to double bed capacity.
- Call
- Guides 30% growth
Yatharth Hospital & Trauma Care Services Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 4,314 mn (+52% YoY), EBITDA Rs 1,020 mn (23.6% margin), PAT Rs 485 mn (+17% YoY). Advent Rs 3,150 cr primary infusion awaits approvals.
Yatharth Hospital & Trauma Care Services Results Update
Yatharth Hospitals reported a 52% YoY revenue growth to Rs 4,314 million for Q2 FY27. The company also announced a Rs 3,150 crore strategic investment from Advent International.
- Value
- ₹431.4 Cr
- hospital beds
- 3255.0 beds
Yatharth Hospital & Trauma Care Services Q2 FY27 Results: Net Profit ₹48.5 Cr, Up 17.4% YoY
Yatharth Hospital & Trauma Care Services Ltd reported revenue from operations of ₹431.4 Cr (+52.4% YoY) and net profit of ₹48.5 Cr (+17.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹48.5 Cr · +17.4% YoY
Yatharth Hospital & Trauma Care Services Board Meeting Date
Yatharth Hospital intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital & Trauma Care Services Ltd announced the voting results for its Extraordinary General Meeting held on October 15, 2026, where all five resolutions passed.
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.